News, Resources, Updates
A scientific hub to keep you informed about our latest research and company updates.
InnoSer to Present Novel Data at AD/PD 2024 Showcasing in Vitro Neurodegenerative Disease Modelling Capabilities
We are thrilled to announce that InnoSer, as an innovative preclinical contract research organization (CRO), will be actively participating in the upcoming AD/PD 2024 Conference taking place in Lisbon, Portugal on March 5-9, 2024. The theme of AD/PD 2024 is striving...
Getting the Most out of Bioluminescent Imaging for Your Research
The application of bioluminescence imaging (BLI) in preclinical research studies offers quantitative, sensitive, longitudinal real-time data and can be applied in: Validation of cancer cell lines, helping to establish improved preclinical cancer mouse models. ...
The Application of Cystic Index in the ADPKD Mouse Model
The kidneys of autosomal dominant polycystic kidney disease (ADPKD) patients progressively enlarge due to the formation and expansion of fluid-filled cysts. However, currently there is no available therapy for ADPKD patients that targets the growth of cysts,...
The Importance of Including Translational Kidney Function Readouts in Your Preclinical Research: Transdermal GFR Measurement
Preclinical Nephrology Research Preclinical studies aiming to assess kidney function in animal models of kidney disease or in response to a test compound have traditionally included readouts such as serum creatinine and blood urea nitrogen (BUN). However, the use of...
eIF2B Modulators in Vanishing White Matter
Vanishing White Matter (VWM) disease is a rare and fatal leukodystrophy, caused by recessive mutations in the five genes encoding the protein complex eukaryotic translation initiation factor 2B (eIF2B). eIF2B plays a crucial role in initiating and regulating the...
How to ensure that you are working with translationally relevant kidney disease research models?
Although multiple kidney disease models have been described in literature, not all of the models are well-characterized and suitable for preclinical research. To help accelerate the development of new drugs to improve the quality of life of patients living with a...
info@innoserlaboratories.com